公开(公告)号：EP0495131B1

公开(公告)日：1997-05-14

申请号：EP91914201.8

申请日：1991-08-09

申请人： OTSUKA PHARMACEUTICAL CO., LTD.

发明人： NAKAI, Satoru, 67-4, Aza-Minamikawamukou ,  AKAMATSU, Seiji ,  MASUI, Yoshihiro, 1-50, Aza-Shimozao ,  NISHIDA, Tsutomu ,  KAMOGASHIRA, Takashi ,  HIRAI, Yoshikatu

IPC分类号： C12N15/25 ,  A61K38/00 ,  C12P21/02

CPC分类号： C07K14/545 ,  A61K38/00

摘要： An agent for preventing and treating hepatitis, containing at least one member selected among interleukin-1 and its derivatives as the active ingredient, which significantly inhibits the blood GOT and GPT activities as a marker for the onset of hepatitis and also suppresses the presentation of jaundice.

公开(公告)号：EP0495131A1

公开(公告)日：1992-07-22

申请号：EP91914201.8

申请日：1991-08-09

申请人： OTSUKA PHARMACEUTICAL CO., LTD.

发明人： NAKAI, Satoru, 67-4, Aza-Minamikawamukou ,  AKAMATSU, Seiji ,  MASUI, Yoshihiro, 1-50, Aza-Shimozao ,  NISHIDA, Tsutomu ,  KAMOGASHIRA, Takashi ,  HIRAI, Yoshikatu

IPC分类号： C12N15/25 ,  A61K37/02 ,  C12P21/02

CPC分类号： C07K14/545 ,  A61K38/00

摘要： An agent for preventing and treating hepatitis, containing at least one member selected among interleukin-1 and its derivatives as the active ingredient, which significantly inhibits the blood GOT and GPT activities as a marker for the onset of hepatitis and also suppresses the presentation of jaundice.

摘要翻译： 一种预防和治疗肝炎的药物，含有选自白介素-1及其衍生物中的至少一种作为活性成分，其显着抑制血液GOT和GPT活性，作为肝炎发病的标志物，并且还抑制黄疸的出现 。